BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24141960)

  • 1. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children.
    Nassef YE; Shady MM; Galal EM; Hamed MA
    Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):887-93. PubMed ID: 24141960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
    Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
    PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
    El Guesiry D; Moez P; Hossam N; Kassem M
    Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
    Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
    Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
    Puigvehí M; Hernández J; Broquetas T; Coll S; Garcia-Retortillo M; Cañete N; Giménez MD; Garcia M; Bory F; Salvadó M; Solà R; Carrión JA
    PLoS One; 2016; 11(12):e0164883. PubMed ID: 27984583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
    Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
    Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
    Larrousse M; Laguno M; Segarra M; De Lazzari E; Martinez E; Blanco JL; León A; Deulofeu R; Miquel R; Milinkovic A; Lonca M; Miró JM; Biglia A; Murillas J; Gatell JM; Mallolas J
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):304-11. PubMed ID: 18172937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
    Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis.
    Lidbury JA; Hoffmann AR; Fry JK; Suchodolski JS; Steiner JM
    Can J Vet Res; 2016 Oct; 80(4):302-308. PubMed ID: 27733785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C.
    Catanzaro R; Milazzo M; Arona S; Sapienza C; Vasta D; Arcoria D; Marotta F
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):500-7. PubMed ID: 24103280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
    Boeker KH; Haberkorn CI; Michels D; Flemming P; Manns MP; Lichtinghagen R
    Clin Chim Acta; 2002 Feb; 316(1-2):71-81. PubMed ID: 11750276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.
    Murawaki Y; Ikuta Y; Okamoto K; Koda M; Kawasaki H
    J Gastroenterol; 2001 Jun; 36(6):399-406. PubMed ID: 11428586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major.
    El-Shabrawi MH; Zein El Abedin MY; Omar N; Kamal NM; Elmakarem SA; Khattab S; El-Sayed HM; El-Hennawy A; Ali AS
    Arab J Gastroenterol; 2012 Jun; 13(2):45-8. PubMed ID: 22980590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
    Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
    Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.